Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) yesterday and set a price target of ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Walmart’s latest brand and logo update has left some social media ... In a statement, William White, senior vice president and chief marketing officer, Walmart U.S, said, in part, “This ...

A tongue dances to Shania Twain to promote Nestle's Coffee Mate Cold Foam. A frenzied mix of silliness and celebrities is ...

The championship game is also significant from a cultural standpoint, marking just the second time in Super Bowl history that both starting quarterbacks are Black. When the Eagles' Jalen Hurts ...

Swiss pharma giant Novartis AG NVS reported better-than-expected results for the fourth quarter of 2024. Core earnings (excluding one-time charges) of $1.98 per share easily beat the Zacks ...

Novartis Q4 earnings beat estimates with sales up 16%, driven by strong demand for Entresto, Kesimpta, and Cosentyx. CEO Narasimhan reportedly downplays Entresto's U.S. patent expiration ...

Novartis AG (NYSE:NVS) shares are trading higher in the premarket session on Friday. The Swiss pharma giant reported fourth-quarter adjusted earnings per share of $1.98, beating the street view of ...

The Defense Intelligence Agency has paused activities and events related to Black History Month, Martin Luther King Jr. Day, Juneteenth and other "special observances" to comply with executive ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth. After signing 30 deals ...

2. Please see detailed guidance assumptions on page 7. 3. As defined on page 35 of the Condensed Financial Report, Continuing operations include the retained business activities of Novartis, ...